English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Understanding how dangerous salmonella is: risks explained
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

AstraZeneca’s ATR inhibitor fails to show survival benefit in late-stage lung cancer study
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Aktis Oncology files IPO after multi-month pause in biotech offerings
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Trump Administration finalizes drug price agreements with nine more pharmaceutical firms
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

FDA official’s skepticism impacts Disc Medicine shares amid bitopertin review
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Analysts predict further biotech gains into 2026 amid innovation and regulatory challenges
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

MIT study finds fatty diets push liver cells toward higher cancer risk
+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Strategies for connecting digital advertising with retail store sales

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes